At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 25 enrolled
Drug / intervention
Proellexdrug
Likely dose
Proellex 25 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Safety and Pharmacokinetic Study of 100 mg, 150 mg and 200 mg of Proellex® Taken for Seven Days by Healthy Adult Female Subjects
In Brief
A Phase 1 clinical trial evaluating Proellex for Healthy. Completed, enrolled 25 participants across 1 site.
Detailed Summary
Dose escalating study of 7 daily doses of Proellex at 100 mg, 150 mg and 200 mg
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2008
First PostedFeb 2008
Primary CompletionSep 2008
Study CompletionOct 2008
TodayJul 2026
First PostedFeb 21, 2008
Enrollment StartFeb 1, 2008
Primary CompletionSep 1, 2008
Study CompletionOct 1, 2008
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 18.4 years ago
Interventions
Proellexdrug
Proellex 25 mg capsules 100 mg, 150 mg or 200mg daily for 7 days